Frontlight ResearchEarly access
CompletedNo phase
TVMR With the Innovalve System Trial - Pilot in Georgia
Key facts
- Who runs it
- Edwards Lifesciences
- Where
- Georgia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 11 people enrolled
- Started
- 1 Dec 2021
- Ended
- 1 Jan 2025
- Type of study
- Interventional
- Treatments tested
- Innovalve MR system
- Record updated
- 23 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Clinically significant, symptomatic mitral regurgitation
- High risk for open-heart surgery
- Meets anatomical criteria
Who cannot take part
- Unsuitable anatomy
- Patient is inoperable
- EF<25%
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Study to evaluate the safety and performance of the Innovalve mitral valve replacement system
The group in the trial
- Innovalve TMVR SystemTreatment being tested
MV replacement with Innovalve MR system
Treatment: Innovalve MR system
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 April 2025